| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 2 |
| 1 | ACETAMINOPHEN | 1 |
| 2 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 3 | ADALIMUMAB | 1 |
| 4 | ADALIMUMAB-AATY | 1 |
| 5 | AMINOCAPROIC ACID | 1 |
| 6 | CEVIMELINE | 1 |
| 7 | CEVIMELINE HYDROCHLORIDE | 1 |
| 8 | DENOSUMAB | 1 |
| 9 | ETODOLAC | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 1 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 2 | ETODOLAC | 1 | 0.0002 |
| 3 | TRANEXAMIC ACID | 1 | 0.0001 |
| 4 | IPRATROPIUM BROMIDE | 1 | 0.0000 |
| 5 | UPADACITINIB | 2 | 0.0000 |
| 6 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 7 | FAMOTIDINE | 1 | 0.0000 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | DENOSUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 2 |
| 1 | Antifibrinolytic Agent [EPC] | 1 |
| 2 | Expectorant [EPC] | 1 |
| 3 | Histamine-2 Receptor Antagonist [EPC] | 1 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| 5 | RANK Ligand Inhibitor [EPC] | 1 |
| 6 | Vitamin B12 [EPC] | 1 |
| 7 | Vitamin C [EPC] | 1 |
| 8 | Vitamin D [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 1 | Janus Kinase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Expectorant [EPC] | 1 | 0.0000 |
| 5 | Vitamin D [EPC] | 1 | 0.0000 |
| 6 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 7 | Vitamin C [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |